dc.contributor.author | Yilmaz, T. | |
dc.contributor.author | Satman, I. | |
dc.contributor.author | Karsidag, K. | |
dc.contributor.author | Turker, F. | |
dc.contributor.author | Omer, B. | |
dc.contributor.author | Dinccag, N. | |
dc.contributor.author | Kalaca, S. | |
dc.contributor.author | Toumilehto, J. | |
dc.contributor.author | Genc, S. | |
dc.contributor.author | Gedik, S. | |
dc.contributor.author | Tutuncu, Yıldız | |
dc.contributor.author | Cambaz, B. | |
dc.date.accessioned | 2021-03-05T12:28:50Z | |
dc.date.available | 2021-03-05T12:28:50Z | |
dc.identifier.citation | Dinccag N., Satman I., Kalaca S., Omer B., Karsidag K., Yilmaz T., Tutuncu Y., Genc S., Gedik S., Turker F., et al., "The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey", 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, Portekiz, 12 - 16 Eylül 2011, cilt.54 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ad623a78-413c-4943-8b7f-68a5825f22ce | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/115684 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | The prevalence of the metabolic syndrome is comparable using the nation specific IDF, WHO and NECP-ATP III criteria in Turkey | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 54 | |
dc.contributor.firstauthorID | 138582 | |